It wasn't clear to me in the MOU with ICL back in April whether products had been developed at that point and time. Today's announcement seems to indicate that is the case, and we are now at a stage of determining sales and distribution of those products.
As per announcement
"As previously announced, the Company entered into a Memorandum of Understanding with ICL for the distribution, manufacturing and development of Alexiflam® NF products to global markets. Progress with ICL is proceeding well as both parties have focused on the sales/distribution strategy for launching Alexiflam® NF with ICL.Details around the structure of the agreement and commercialization strategy cannot be discussed at this time but will be shared when appropriate. In parallel with this effort, the Company continues its internal commercial efforts with Alexiflam® NF for key markets which the Company will retain sales rights"
AJX Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
